ヘパリン起因性血小板減少症：急性期脳梗塞診療における頻度と特徴
スポンサーリンク
概要
- 論文の詳細を見る
Background and purpose: We estimated the incidence of heparin-induced thrombocytopenia (HIT) in acute ischemic stroke and investigated clinical features of the HIT patients.Methods: Of 1,078 consecutive patients with acute ischemic stroke, 392 were treated with intravenous unfractionated heparin (UFH). Ten of them showed prominent thrombocytopenia without evident causes and were suspected to have HIT. We studied these 10 patients retrospectively. Clinical diagnosis of HIT was made according to the two scoring systems. Antibodies against heparin-platelet factor 4 complexes in plasma were detected by enzyme-linked immunosorbent assay (ELISA) and were confirmed by 14C-serotonin release assay.Results: Eight patients were clinically suspected of having HIT according to both the scoring systems. Of them, serological tests were positive in 2 patients only by ELISA and in 2 by both the assays. Amount of UFH administered was larger in 4 patients with positive serological findings than the others. Three patients developed thromboembolic events. Two patients were died and the remaining 6 patients were dependent at the time of hospital discharge. Clinical severity and outcome of all the 8 patients were unfavorable regardless of serological findings.Conclusions: Prevalence of HIT was 0.5% after ascertainment by serological assays. One should never neglect this serious complication when treating stroke.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.